Accelerating the Pace of Drug Discovery through A.I. with BMS CDTO Greg Meyers

November 17, 2022

More Ways to Listen

LISTEN TO PODCAST

Subscribe on Your Favorite Platform

Other Platforms

About the Guest

Greg Meyers

EVP & Chief Digital and Technology Officer of Bristol Myers Squibb

Greg Meyers is the Executive Vice President and Chief Digital and Technology Officer of Bristol Myers Squibb, a global biopharmaceutical company with nearly $48 billion in annual revenue. Greg has been in that position for nearly a year. He plays an extraordinarily strategic role at BMS, leading a cross-disciplinary team that drives better outcomes for patients while having a profound impact on both the top and bottom lines of the company. Before his current role, Greg was the Chief Information and Digital Officer of Syngenta Group in Basel, Switzerland; before that, he was the CIO of Motorola Solutions.

Episode Overview

716: Greg discusses the innovations in digital health that he is driving and how they have accelerated the pace of drug discovery. He gives an overview of BMS’s business and the company’s digital health program as well as how collaboration with physicians and hiring for various skills have been critical in developing game-changing innovations. Greg also covers the way his team collaborates internally across the silos within the organization and leverages technologies like artificial intelligence to increase the speed at which drugs are tested and developed. Finally, he explains why he chooses to immerse himself deeply in more technical aspects of the business, looks ahead at what trends in technology he believes will continue to make important contributions to healthcare, and reflects on the keys to his career success.

Podcast: Play in new window | Download